ISIV-NASDAQ US BIOTE. DLA ETF · IE00BYXG2H39 · A2DWAW (XDUB) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of ISIV-NASDAQ US BIOTE. DLA

No Price

01.05.2026 15:14

Current Prices from ISIV-NASDAQ US BIOTE. DLA

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
London	BTEC.L	USD	01.05.2026 15:14	8,48 USD	-0,06 USD -0,67 %
London	BTEK.L	GBP	01.05.2026 15:12	6,22 GBP	-0,06 GBP -0,99 %
Düsseldorf	SIVNAS39.DUSB	EUR	30.04.2026 19:47	7,25 EUR	-
XETRA	2B70.DE	EUR	30.04.2026 15:36	7,28 EUR	-
Hamburg	SIVNAS39.HAMB	EUR	30.04.2026 12:05	7,19 EUR	-
Quotrix	SIVNAS39.DUSD	EUR	30.04.2026 05:27	7,16 EUR	-

Asset Allocation

Asset	Percentage %
Keine Daten vorhanden

Largest Positions

Symbol	ISIN	Name	Percentage %
Keine Daten vorhanden

Region Distribution

Region	Percentage %
Keine Daten vorhanden

Sector Distribution

Sector	Percentage %
Keine Daten vorhanden

Company Profile for ISIV-NASDAQ US BIOTE. DLA ETF

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Fund Master Data

Issuer iShares IV plc

Asset Class ETF

Name iShares Nasdaq US Biotechnology UCITS ETF

Reference Index Nasdaq Biotechnology Index(R)

Asset Class Aktien

Asset Subclass Small Caps

Fund Currency USD

Total Expense Ratio (TER) 0,35 %

Fund Domicile Vereinigte Staaten von Amerika

Region Nordamerika

Benchmark Index 1628.96

Distribution Type thesaurierend

Markets Industrieländer

Risk Indicator 6

Fund Key Figures

Fund Size 502.869,22 EUR

NAV 7.6

AUM 545,5 M EUR

Number of Shares 66196534

PE Ratio 29.5

PB Ratio 6.74

Sustainability

MSCI ESG Rating A

MSCI Index carbon footprint metrics 20.06

Investment Strategy

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF was formed on October 19, 2017 and is domiciled in Ireland.